Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Short term Debt: 2009-2024

Historic Short term Debt for Fresenius Medical Care AG (FMS) over the last 16 years, with Dec 2024 value amounting to $1.9 billion.

  • Fresenius Medical Care AG's Short term Debt rose 37.73% to $2.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year increase of 37.73%. This contributed to the annual value of $1.9 billion for FY2024, which is 5.38% up from last year.
  • Per Fresenius Medical Care AG's latest filing, its Short term Debt stood at $1.9 billion for FY2024, which was up 5.38% from $1.8 billion recorded in FY2023.
  • Over the past 5 years, Fresenius Medical Care AG's Short term Debt peaked at $1.9 billion during FY2024, and registered a low of $790.5 million during FY2021.
  • Moreover, its 3-year median value for Short term Debt was $1.9 billion (2022), whereas its average is $1.9 billion.
  • In the last 5 years, Fresenius Medical Care AG's Short term Debt crashed by 31.34% in 2021 and then soared by 138.22% in 2022.
  • Over the past 5 years, Fresenius Medical Care AG's Short term Debt (MRY) stood at $1.2 billion in 2020, then plummeted by 31.34% to $790.5 million in 2021, then surged by 138.22% to $1.9 billion in 2022, then decreased by 3.75% to $1.8 billion in 2023, then rose by 5.38% to $1.9 billion in 2024.
  • Its Short term Debt was $1.9 billion in FY2024, compared to $1.8 billion in FY2023 and $1.9 billion in FY2022.